# Jean‐Yves Scoazec

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/jean-yves-scoazec/

## Facts

| Field | Value |
| --- | --- |
| Citations | 34,203 |
| Field | Neuroendocrine Tumor Research Advances |
| h-index | 97 |
| i10-index | 420 |
| Last Known Institution | Inserm |
| OpenAlex ID | https://openalex.org/A5042575799 |
| ORCID iD | https://orcid.org/0000-0003-1604-6823 |
| Works | 1,295 |

## Researcher papers

- [TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system](https://scholariq.org/papers/tnm-staging-of-midgut-and-hindgut-neuro-endocrine-tumors-a-consensus-proposal/)
- [ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumours: Surgery for Small Intestinal and Pancreatic Neuroendocrine Tumours](https://scholariq.org/papers/enets-consensus-guidelines-for-the-standards-of-care-in-neuroendocrine-tumours/)
- [Well-Differentiated Pancreatic Nonfunctioning Tumors/Carcinoma](https://scholariq.org/papers/well-differentiated-pancreatic-nonfunctioning-tumors-carcinoma/)
- [ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Biochemical Markers](https://scholariq.org/papers/enets-consensus-guidelines-for-the-standards-of-care-in-neuroendocrine-tumors-2/)
- [Diverse Resistance Mechanisms to the Third-Generation ALK Inhibitor Lorlatinib in ALK-Rearranged Lung Cancer](https://scholariq.org/papers/diverse-resistance-mechanisms-to-the-third-generation-alk-inhibitor-lorlatinib/)
- [Crizotinib-Resistant <i>ROS1</i> Mutations Reveal a Predictive Kinase Inhibitor Sensitivity Model for <i>ROS1</i> - and <i>ALK</i> -Rearranged Lung Cancers](https://scholariq.org/papers/crizotinib-resistant-i-ros1-i-mutations-reveal-a-predictive-kinase-inhibitor/)
- [Recurrent Alcoholic Cirrhosis In Severe Alcoholic Relapse After Liver Transplantation: A Frequent and Serious Complication](https://scholariq.org/papers/recurrent-alcoholic-cirrhosis-in-severe-alcoholic-relapse-after-liver/)

## Researcher topics

- [Neuroendocrine Tumor Research Advances](https://scholariq.org/topics/neuroendocrine-tumor-research-advances/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Prostate Cancer Treatment and Research](https://scholariq.org/topics/prostate-cancer-treatment-and-research/)
- [Fibroblast Growth Factor Research](https://scholariq.org/topics/fibroblast-growth-factor-research/)
- [Pancreatic and Hepatic Oncology Research](https://scholariq.org/topics/pancreatic-and-hepatic-oncology-research/)

## Researcher university

- [Inserm](https://scholariq.org/institutions/inserm/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.